 Michael Zaretsky
Concepts (271)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetal Therapies | 13 | 2026 | 47 | 3.660 |
Why?
| | Fetal Diseases | 10 | 2026 | 191 | 2.160 |
Why?
| | Meningomyelocele | 9 | 2025 | 61 | 1.750 |
Why?
| | Ultrasonography, Prenatal | 18 | 2025 | 294 | 1.590 |
Why?
| | Pregnancy | 62 | 2026 | 7190 | 1.520 |
Why?
| | Fetoscopy | 6 | 2025 | 33 | 1.410 |
Why?
| | Fetofetal Transfusion | 4 | 2025 | 26 | 1.410 |
Why?
| | Prenatal Care | 6 | 2023 | 307 | 1.300 |
Why?
| | Airway Obstruction | 4 | 2025 | 162 | 1.100 |
Why?
| | Fetus | 10 | 2023 | 803 | 1.060 |
Why?
| | Cesarean Section | 9 | 2026 | 224 | 0.990 |
Why?
| | Prenatal Diagnosis | 7 | 2025 | 195 | 0.950 |
Why?
| | Hernias, Diaphragmatic, Congenital | 6 | 2025 | 219 | 0.930 |
Why?
| | Magnetic Resonance Imaging | 17 | 2025 | 3863 | 0.870 |
Why?
| | Cystic Fibrosis | 4 | 2026 | 1158 | 0.800 |
Why?
| | Gestational Age | 17 | 2023 | 975 | 0.770 |
Why?
| | Oligohydramnios | 4 | 2023 | 12 | 0.670 |
Why?
| | Laryngeal Diseases | 1 | 2021 | 31 | 0.660 |
Why?
| | Anesthetics, Local | 3 | 2022 | 100 | 0.610 |
Why?
| | Uterine Cervical Incompetence | 1 | 2019 | 3 | 0.600 |
Why?
| | Cerclage, Cervical | 1 | 2019 | 9 | 0.600 |
Why?
| | Bupivacaine | 2 | 2020 | 38 | 0.590 |
Why?
| | Tracheostomy | 1 | 2021 | 142 | 0.590 |
Why?
| | Hysterotomy | 2 | 2021 | 9 | 0.580 |
Why?
| | Pregnancy Outcome | 7 | 2024 | 476 | 0.570 |
Why?
| | Lymphoma, T-Cell | 1 | 2018 | 29 | 0.560 |
Why?
| | Infant, Newborn | 20 | 2026 | 6429 | 0.560 |
Why?
| | Lymphohistiocytosis, Hemophagocytic | 1 | 2018 | 29 | 0.560 |
Why?
| | Morphine | 2 | 2022 | 168 | 0.550 |
Why?
| | Pregnancy Complications, Neoplastic | 1 | 2018 | 63 | 0.540 |
Why?
| | Natural Killer T-Cells | 1 | 2018 | 67 | 0.540 |
Why?
| | Female | 66 | 2026 | 78271 | 0.540 |
Why?
| | Oxycodone | 1 | 2018 | 53 | 0.540 |
Why?
| | Laser Therapy | 1 | 2019 | 135 | 0.510 |
Why?
| | Opioid-Related Disorders | 3 | 2022 | 600 | 0.500 |
Why?
| | Acetaminophen | 1 | 2018 | 264 | 0.450 |
Why?
| | Meconium Ileus | 2 | 2026 | 12 | 0.450 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.440 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.440 |
Why?
| | Retrospective Studies | 29 | 2025 | 17066 | 0.430 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 3 | 2026 | 370 | 0.400 |
Why?
| | Humans | 67 | 2026 | 144759 | 0.390 |
Why?
| | Pelvis | 2 | 2003 | 124 | 0.370 |
Why?
| | Pandemics | 1 | 2020 | 1694 | 0.340 |
Why?
| | Lung Volume Measurements | 3 | 2023 | 46 | 0.330 |
Why?
| | Obstetric Surgical Procedures | 2 | 2021 | 6 | 0.320 |
Why?
| | Respiratory System Abnormalities | 2 | 2023 | 18 | 0.320 |
Why?
| | Gastroschisis | 2 | 2020 | 32 | 0.300 |
Why?
| | Analgesia, Obstetrical | 2 | 2021 | 32 | 0.300 |
Why?
| | Hydrocephalus | 2 | 2022 | 111 | 0.280 |
Why?
| | Pregnancy Complications | 3 | 2024 | 592 | 0.280 |
Why?
| | Placenta | 4 | 2021 | 780 | 0.280 |
Why?
| | Fetal Heart | 2 | 2019 | 57 | 0.280 |
Why?
| | Urogenital Abnormalities | 2 | 2005 | 71 | 0.270 |
Why?
| | Adult | 24 | 2026 | 40449 | 0.260 |
Why?
| | Indomethacin | 2 | 2018 | 76 | 0.250 |
Why?
| | Ductus Arteriosus | 2 | 2018 | 72 | 0.250 |
Why?
| | Heart Rate, Fetal | 1 | 2026 | 31 | 0.240 |
Why?
| | Pelvimetry | 1 | 2005 | 2 | 0.240 |
Why?
| | Cephalopelvic Disproportion | 1 | 2005 | 2 | 0.240 |
Why?
| | Dystocia | 1 | 2005 | 12 | 0.230 |
Why?
| | Uterus | 2 | 2005 | 226 | 0.230 |
Why?
| | Bradycardia | 1 | 2026 | 59 | 0.230 |
Why?
| | Atrioventricular Block | 1 | 2026 | 45 | 0.230 |
Why?
| | Aminophenols | 2 | 2026 | 201 | 0.230 |
Why?
| | Fetal Growth Retardation | 3 | 2025 | 587 | 0.230 |
Why?
| | Abortion, Spontaneous | 2 | 2023 | 115 | 0.230 |
Why?
| | Cell-Free Nucleic Acids | 1 | 2025 | 33 | 0.220 |
Why?
| | Mediastinal Neoplasms | 1 | 2025 | 51 | 0.220 |
Why?
| | Herniorrhaphy | 1 | 2025 | 74 | 0.220 |
Why?
| | Laser Coagulation | 1 | 2025 | 77 | 0.210 |
Why?
| | Body Mass Index | 3 | 2025 | 2438 | 0.210 |
Why?
| | Teratoma | 1 | 2025 | 120 | 0.210 |
Why?
| | Bartter Syndrome | 1 | 2023 | 7 | 0.210 |
Why?
| | Polyhydramnios | 1 | 2023 | 17 | 0.210 |
Why?
| | Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2023 | 5 | 0.200 |
Why?
| | Bronchopulmonary Sequestration | 1 | 2023 | 8 | 0.200 |
Why?
| | Isotonic Solutions | 1 | 2023 | 39 | 0.200 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 2018 | 338 | 0.200 |
Why?
| | Genetic Testing | 2 | 2025 | 478 | 0.200 |
Why?
| | Placental Circulation | 1 | 2004 | 70 | 0.200 |
Why?
| | Hernia, Umbilical | 1 | 2023 | 21 | 0.200 |
Why?
| | Balloon Occlusion | 1 | 2023 | 39 | 0.200 |
Why?
| | Ultrasonography | 4 | 2021 | 770 | 0.190 |
Why?
| | Premature Birth | 2 | 2023 | 380 | 0.190 |
Why?
| | Maternal-Fetal Exchange | 1 | 2004 | 169 | 0.190 |
Why?
| | Amniotic Fluid | 4 | 2022 | 79 | 0.180 |
Why?
| | Drug Combinations | 2 | 2024 | 390 | 0.170 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2025 | 383 | 0.170 |
Why?
| | Gynecology | 1 | 2024 | 178 | 0.170 |
Why?
| | Workflow | 1 | 2023 | 184 | 0.170 |
Why?
| | Renal Insufficiency | 1 | 2023 | 168 | 0.170 |
Why?
| | Infant | 8 | 2023 | 10034 | 0.170 |
Why?
| | Birth Weight | 2 | 2004 | 522 | 0.170 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2022 | 123 | 0.170 |
Why?
| | Retrognathia | 1 | 2020 | 4 | 0.170 |
Why?
| | Anesthesia, Obstetrical | 1 | 2021 | 30 | 0.170 |
Why?
| | Obstetric Labor Complications | 1 | 2021 | 38 | 0.160 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2023 | 239 | 0.160 |
Why?
| | Pyrazoles | 1 | 2024 | 509 | 0.160 |
Why?
| | Indoles | 1 | 2024 | 501 | 0.160 |
Why?
| | Micrognathism | 1 | 2020 | 19 | 0.160 |
Why?
| | Pyridines | 1 | 2024 | 605 | 0.160 |
Why?
| | Head and Neck Neoplasms | 1 | 2025 | 558 | 0.160 |
Why?
| | Ultrasonography, Doppler | 2 | 2019 | 126 | 0.160 |
Why?
| | Interleukin-1 | 1 | 2004 | 961 | 0.160 |
Why?
| | Interleukin-6 | 1 | 2004 | 780 | 0.150 |
Why?
| | Imaging, Three-Dimensional | 3 | 2015 | 583 | 0.150 |
Why?
| | Amniocentesis | 1 | 2019 | 20 | 0.150 |
Why?
| | Kidney Diseases | 1 | 2023 | 427 | 0.150 |
Why?
| | Blood Flow Velocity | 2 | 2018 | 413 | 0.150 |
Why?
| | Risk Assessment | 4 | 2025 | 3671 | 0.150 |
Why?
| | Pulsatile Flow | 2 | 2019 | 55 | 0.150 |
Why?
| | Comorbidity | 1 | 2024 | 1658 | 0.150 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2004 | 1217 | 0.150 |
Why?
| | Anorectal Malformations | 1 | 2021 | 113 | 0.140 |
Why?
| | Maternal Health | 1 | 2019 | 52 | 0.140 |
Why?
| | Tocolytic Agents | 1 | 2018 | 16 | 0.140 |
Why?
| | Anesthesia, Spinal | 1 | 2018 | 13 | 0.140 |
Why?
| | Anesthesiology | 1 | 2021 | 175 | 0.140 |
Why?
| | Surgical Wound | 1 | 2018 | 27 | 0.140 |
Why?
| | Analgesia, Epidural | 1 | 2018 | 38 | 0.130 |
Why?
| | Ibuprofen | 1 | 2018 | 84 | 0.130 |
Why?
| | Fatal Outcome | 1 | 2018 | 307 | 0.130 |
Why?
| | Maternal Exposure | 1 | 2020 | 213 | 0.130 |
Why?
| | Urethral Obstruction | 1 | 2017 | 8 | 0.130 |
Why?
| | Lung | 7 | 2023 | 4109 | 0.130 |
Why?
| | Treatment Failure | 1 | 2018 | 365 | 0.130 |
Why?
| | Anesthesia | 1 | 2021 | 258 | 0.130 |
Why?
| | Predictive Value of Tests | 4 | 2025 | 2115 | 0.130 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2018 | 2027 | 0.130 |
Why?
| | Lung Diseases | 1 | 2023 | 787 | 0.120 |
Why?
| | Analgesics, Opioid | 3 | 2022 | 1143 | 0.120 |
Why?
| | Lateral Ventricles | 1 | 2016 | 32 | 0.120 |
Why?
| | Registries | 5 | 2025 | 2385 | 0.120 |
Why?
| | Decision Making | 1 | 2023 | 975 | 0.120 |
Why?
| | North America | 3 | 2023 | 310 | 0.120 |
Why?
| | Labor, Induced | 2 | 2007 | 39 | 0.110 |
Why?
| | Treatment Outcome | 7 | 2026 | 11679 | 0.110 |
Why?
| | Perioperative Period | 1 | 2015 | 71 | 0.110 |
Why?
| | Nifedipine | 1 | 2014 | 27 | 0.110 |
Why?
| | Ventricular Dysfunction | 1 | 2014 | 16 | 0.110 |
Why?
| | Pain Management | 1 | 2018 | 405 | 0.100 |
Why?
| | Anesthesia, General | 1 | 2015 | 118 | 0.100 |
Why?
| | Fetal Weight | 2 | 2004 | 54 | 0.100 |
Why?
| | Prospective Studies | 5 | 2025 | 7990 | 0.100 |
Why?
| | Calcium Channel Blockers | 1 | 2014 | 165 | 0.100 |
Why?
| | Heart Ventricles | 1 | 2018 | 760 | 0.100 |
Why?
| | ROC Curve | 2 | 2005 | 614 | 0.100 |
Why?
| | Quinolones | 2 | 2026 | 201 | 0.090 |
Why?
| | United States | 2 | 2020 | 15966 | 0.090 |
Why?
| | Fetal Death | 2 | 2023 | 58 | 0.090 |
Why?
| | Echo-Planar Imaging | 2 | 2009 | 23 | 0.080 |
Why?
| | Cardiomyopathies | 1 | 2014 | 338 | 0.080 |
Why?
| | Hypertension, Pulmonary | 1 | 2022 | 1980 | 0.080 |
Why?
| | Risk Factors | 6 | 2025 | 10779 | 0.080 |
Why?
| | Obesity | 2 | 2025 | 3077 | 0.080 |
Why?
| | Sensitivity and Specificity | 2 | 2005 | 1985 | 0.080 |
Why?
| | Cervical Ripening | 2 | 2007 | 9 | 0.080 |
Why?
| | Follow-Up Studies | 2 | 2017 | 5408 | 0.080 |
Why?
| | Appendix | 1 | 2009 | 31 | 0.070 |
Why?
| | Young Adult | 4 | 2020 | 14105 | 0.070 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1953 | 0.070 |
Why?
| | Labor Onset | 1 | 2007 | 2 | 0.060 |
Why?
| | Pregnancy Trimester, Third | 2 | 2022 | 115 | 0.060 |
Why?
| | Carotid Stenosis | 1 | 2008 | 102 | 0.060 |
Why?
| | Pregnancy, Prolonged | 1 | 2005 | 2 | 0.060 |
Why?
| | Umbilical Cord | 1 | 2026 | 91 | 0.060 |
Why?
| | Pelvic Floor | 1 | 2005 | 32 | 0.060 |
Why?
| | Meconium | 1 | 2005 | 7 | 0.060 |
Why?
| | Colorado | 3 | 2021 | 4564 | 0.060 |
Why?
| | Digestive System Abnormalities | 1 | 2005 | 15 | 0.060 |
Why?
| | Epinephrine | 1 | 2026 | 155 | 0.060 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2008 | 228 | 0.060 |
Why?
| | Time Factors | 4 | 2019 | 7173 | 0.060 |
Why?
| | Urine | 1 | 2005 | 62 | 0.060 |
Why?
| | Fetal Distress | 1 | 2004 | 14 | 0.060 |
Why?
| | Muscle, Smooth | 1 | 2005 | 153 | 0.050 |
Why?
| | Sampling Studies | 1 | 2004 | 99 | 0.050 |
Why?
| | Statistics, Nonparametric | 1 | 2005 | 427 | 0.050 |
Why?
| | Culture Techniques | 1 | 2004 | 67 | 0.050 |
Why?
| | Confidence Intervals | 1 | 2004 | 333 | 0.050 |
Why?
| | Infusions, Parenteral | 1 | 2023 | 41 | 0.050 |
Why?
| | Chloride Channel Agonists | 1 | 2024 | 109 | 0.050 |
Why?
| | Pyrrolidines | 1 | 2024 | 125 | 0.050 |
Why?
| | Alprostadil | 1 | 2003 | 29 | 0.050 |
Why?
| | Misoprostol | 1 | 2003 | 15 | 0.050 |
Why?
| | Dissent and Disputes | 1 | 2023 | 18 | 0.050 |
Why?
| | Pregnancy Trimesters | 1 | 2003 | 20 | 0.050 |
Why?
| | Male | 6 | 2025 | 72315 | 0.050 |
Why?
| | Stents | 1 | 2008 | 556 | 0.050 |
Why?
| | Quinolines | 1 | 2024 | 193 | 0.050 |
Why?
| | Animals | 1 | 2026 | 38058 | 0.050 |
Why?
| | Oxytocin | 1 | 2003 | 51 | 0.050 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2024 | 120 | 0.050 |
Why?
| | Steroids | 1 | 2023 | 160 | 0.050 |
Why?
| | Congenital Abnormalities | 1 | 2023 | 104 | 0.050 |
Why?
| | Benzodioxoles | 1 | 2024 | 158 | 0.050 |
Why?
| | Feasibility Studies | 2 | 2005 | 1095 | 0.050 |
Why?
| | Morbidity | 1 | 2023 | 323 | 0.050 |
Why?
| | Prognosis | 2 | 2022 | 4282 | 0.050 |
Why?
| | Reference Values | 1 | 2004 | 797 | 0.050 |
Why?
| | Patient Care | 1 | 2023 | 118 | 0.050 |
Why?
| | Ultrasonography, Interventional | 1 | 2023 | 160 | 0.050 |
Why?
| | Antigens, Neoplasm | 1 | 2023 | 271 | 0.040 |
Why?
| | Delphi Technique | 1 | 2024 | 329 | 0.040 |
Why?
| | Preoperative Care | 1 | 2004 | 379 | 0.040 |
Why?
| | Abnormalities, Multiple | 1 | 2023 | 197 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2020 | 3604 | 0.040 |
Why?
| | Trachea | 1 | 2023 | 261 | 0.040 |
Why?
| | Survival Rate | 2 | 2022 | 2089 | 0.040 |
Why?
| | Obstetrics | 1 | 2003 | 175 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2023 | 427 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 405 | 0.040 |
Why?
| | Central Nervous System | 1 | 2003 | 281 | 0.040 |
Why?
| | Respiration, Artificial | 1 | 2025 | 708 | 0.040 |
Why?
| | Anal Canal | 1 | 2021 | 102 | 0.040 |
Why?
| | Airway Management | 1 | 2020 | 79 | 0.040 |
Why?
| | Maternal Age | 1 | 2020 | 126 | 0.040 |
Why?
| | Length of Stay | 1 | 2025 | 1337 | 0.040 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2021 | 192 | 0.040 |
Why?
| | Uterine Rupture | 1 | 2019 | 8 | 0.040 |
Why?
| | Perinatal Death | 1 | 2019 | 26 | 0.040 |
Why?
| | Middle Cerebral Artery | 1 | 2019 | 56 | 0.040 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2019 | 44 | 0.040 |
Why?
| | Umbilical Arteries | 1 | 2019 | 52 | 0.040 |
Why?
| | Live Birth | 1 | 2019 | 68 | 0.040 |
Why?
| | Consensus | 1 | 2021 | 488 | 0.040 |
Why?
| | Infant Mortality | 1 | 2019 | 123 | 0.040 |
Why?
| | Constriction | 1 | 2018 | 47 | 0.040 |
Why?
| | Stroke | 1 | 2008 | 1256 | 0.040 |
Why?
| | Head | 1 | 2019 | 120 | 0.040 |
Why?
| | Cigarette Smoking | 1 | 2020 | 99 | 0.030 |
Why?
| | Infant, Small for Gestational Age | 1 | 2018 | 109 | 0.030 |
Why?
| | Child | 3 | 2023 | 22633 | 0.030 |
Why?
| | Postoperative Complications | 2 | 2021 | 2919 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2022 | 1053 | 0.030 |
Why?
| | Enteral Nutrition | 1 | 2019 | 216 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2003 | 851 | 0.030 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 914 | 0.030 |
Why?
| | Kidney | 1 | 2023 | 1495 | 0.030 |
Why?
| | Blood Transfusion | 1 | 2019 | 405 | 0.030 |
Why?
| | Anesthesia, Inhalation | 1 | 2015 | 14 | 0.030 |
Why?
| | Anesthesia, Intravenous | 1 | 2015 | 24 | 0.030 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2015 | 31 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2015 | 312 | 0.030 |
Why?
| | Parents | 1 | 2023 | 1403 | 0.030 |
Why?
| | Liver | 1 | 2022 | 1887 | 0.030 |
Why?
| | Health Status | 1 | 2019 | 836 | 0.020 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2015 | 182 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2008 | 780 | 0.020 |
Why?
| | Echocardiography | 1 | 2015 | 652 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3409 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 3185 | 0.020 |
Why?
| | Hemodynamics | 1 | 2015 | 1121 | 0.020 |
Why?
| | Biometry | 1 | 2008 | 68 | 0.020 |
Why?
| | Israel | 1 | 2008 | 46 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2015 | 2947 | 0.020 |
Why?
| | Angiography | 1 | 2008 | 208 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 6048 | 0.020 |
Why?
| | Cohort Studies | 1 | 2015 | 5960 | 0.010 |
Why?
| | Needs Assessment | 1 | 2007 | 404 | 0.010 |
Why?
| | Injections, Intravenous | 1 | 2003 | 200 | 0.010 |
Why?
| | Parity | 1 | 2003 | 109 | 0.010 |
Why?
| | Colon | 1 | 2005 | 304 | 0.010 |
Why?
| | Incidence | 1 | 2008 | 2879 | 0.010 |
Why?
| | Administration, Oral | 1 | 2003 | 847 | 0.010 |
Why?
| | Databases, Factual | 1 | 2005 | 1486 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2008 | 2730 | 0.010 |
Why?
| | Aged | 1 | 2008 | 25913 | 0.000 |
Why?
| | Adolescent | 1 | 2005 | 22428 | 0.000 |
Why?
|
|
Zaretsky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|